The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer

Conclusion: The variation in outcomes from RAI therapy of DTC may be explained, among other factors, by the range of absorbed doses delivered. The ability to assess the effect of treatments that modulate RAI uptake, and to estimate the absorbed doses at therapy, introduces the potential for patient stratification using a theranostic approach. Patient-specific absorbed dose planning might be the key to more successful treatment of advanced DTC.

Source: Journal of Nuclear Medicine - June 30, 2023 Category: Nuclear Medicine Authors: Taprogge, J., Abreu, C., Yusuf, S., Ainsworth, G., Phillip, R. H., Gear, J. I., Gregory, R., Leek, F., Murray, I., Coulson, A. B., Brown, S. R., Du, Y., Newbold, K., Wadsley, J., Flux, G. D. Tags: Clinical Investigations Source Type: research